Revolution Medicines Inc (RVMD)

NASDAQ
27.02
-1.85(-6.41%)
After Hours
25.06
-1.96(-7.25%)
- Real-time Data
  • Volume:
    386,619
  • Bid/Ask:
    25.01/35.00
  • Day's Range:
    25.83 - 28.32

RVMD Overview

Prev. Close
28.87
Day's Range
25.83-28.32
Revenue
28.68M
Open
28.11
52 wk Range
21.78-56.18
EPS
-2.37
Volume
386,619
Market Cap
1.99B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
451,647
P/E Ratio
-
Beta
-
1-Year Change
-38.55%
Shares Outstanding
73,687,114
Next Earnings Date
Mar 01, 2022
What is your sentiment on Revolution Medicines Inc?
or
Market is currently closed. Voting is open during market hours.

Revolution Medicines Inc Company Profile

Employees
162

Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also develops RMC-5845, a selective inhibitor of SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a hyperactivated selective inhibitor of mTORC1 signaling in tumors. In addition, the company is developing RMC-6291, a mutant-selective inhibitor of KRASG12C(ON) and NRASG12C(ON); and RMC-6236, a RAS-selective inhibitor of multiple RAS(ON) variants. Further, it develops RAS(ON) Inhibitors targeting KRASG13C(ON) and KRASG12D(ON). Revolution Medicines, Inc. has a collaboration agreement with Sanofi for the research and development of SHP2 inhibitors, including RMC-4630. The company was incorporated in 2014 and is headquartered in Redwood City, California.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellSell
Technical IndicatorsStrong BuyNeutralStrong SellStrong SellStrong Sell
SummaryNeutralNeutralStrong SellStrong SellStrong Sell
  • buy
    0
    • boy or skip?
      0
      • to entry or not to entry Mr. Ilya ?
        0
        • Looks good
          1
          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.